Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RBR-6td87pqNot yet recruiting
Open-label, single-arm trial of bupivacaine in hip osteoarthritis, sponsored by Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo. Primary endpoints: Effective analgesia at 30 minutes, Minimum effective volume in 50% of patients and 1 more. Planned start Jul 2023; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on RBR-6td87pq.